• Potential indications |
– Dyspnea at rest or with exertion |
– Inspiratory muscle weakness (<70% of the predicted value) |
– Pulmonary hypertension |
• Potential contraindications |
– Markedly elevated left ventricular end-diastolic volume and pressure |
– Worsening heart failure signs and symptoms after IMT is initiated† |
– Desaturation with IMT‡ |
– Paradoxical breathing pattern† |
– Worsening inspiratory muscle performance†,§ |
– Persistent diaphragmatic/abdominal/thoracic/inspiratory accessory muscle discomfort† |
Modify IMT prescription if observed.
Consider providing supplemental oxygen if oxygen saturation is observed to decrease from resting levels.
Worsening inspiratory muscle performance defined as an inability to repeatedly achieve MIP, sustained MIP, inspiratory endurance or inspiratory duration achieved during previous IMT sessions.
IMT: Inspiratory muscle training; MIP: Maximal inspiratory pressure.